Literature DB >> 32454240

Crystal structure of a class III adenylyl cyclase-like ATP-binding protein from Pseudomonas aeruginosa.

Juergen Linder1, Enrico Hupfeld1, Michael Weyand1, Clemens Steegborn1, Sébastien Moniot2.   

Abstract

In many organisms, the ubiquitous second messenger cAMP is formed by at least one member of the adenylyl cyclase (AC) Class III. These ACs feature a conserved dimeric catalytic core architecture, either through homodimerization or through pseudo-heterodimerization of a tandem of two homologous catalytic domains, C1 and C2, on a single protein chain. The symmetric core features two active sites, but in the C1-C2 tandem one site degenerated into a regulatory center. Analyzing bacterial AC sequences, we identified a Pseudomonas aeruginosa AC-like protein (PaAClp) that shows a surprising swap of the catalytic domains, resulting in an unusual C2-C1 arrangement. We cloned and recombinantly produced PaAClp. The protein bound nucleotides but showed no AC or guanylyl cyclase activity, even in presence of a variety of stimulating ligands of other ACs. Solving the crystal structure of PaAClp revealed an overall structure resembling active class III ACs but pronounced shifts of essential catalytic residues and structural elements. The structure contains a tightly bound ATP, but in a binding mode not suitable for cAMP formation or ATP hydrolysis, suggesting that PaAClp acts as an ATP-binding protein.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AC; ATP-binding; Anomalous scattering; Iodine; cAMP

Mesh:

Substances:

Year:  2020        PMID: 32454240     DOI: 10.1016/j.jsb.2020.107534

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  1 in total

1.  Cyclic CMP and cyclic UMP mediate bacterial immunity against phages.

Authors:  Nitzan Tal; Benjamin R Morehouse; Adi Millman; Avigail Stokar-Avihail; Carmel Avraham; Taya Fedorenko; Erez Yirmiya; Ehud Herbst; Alexander Brandis; Tevie Mehlman; Yaara Oppenheimer-Shaanan; Alexander F A Keszei; Sichen Shao; Gil Amitai; Philip J Kranzusch; Rotem Sorek
Journal:  Cell       Date:  2021-10-12       Impact factor: 66.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.